UK Markets close in 4 hrs

JD.com, Inc. (9618.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
342.800-3.000 (-0.87%)
At close: 4:09PM HKT
Sign in to post a message.
  • W
    Woky
    I just want to give my opinions on recent JD price actions (I have been owning JD since the 20s, so feel free to take these with a healthy dose of salt).

    JD has been trading in a very narrow range since ER - between 85 and 89. Most days were even inside days. More importantly, the volume has been drying up.

    There were couple of reasons I can think of. 1. Continual fall out from Ant IPO (Big brother eyeing). 2. Perceived weaker than expected earnings (These days blowout are default) 3. Rotation into second tier Chinese stocks (LI/XPEV/DADA moved as much as 100% in last 2 weeks ) 4. Rotation out of new economy stocks (Ole HSBC Bank up 20%).

    Long story short, external events are impacting JD. It does feels like we are in a pressure cooker and ready to burst out soon. Hopefully next week will see better days.

    Happy Thanksgiving, folks.
  • s
    soran
    JD Health is offering nearly 382 million shares, with an indicative price range of 62.80 Hong Kong dollars to HK$70.58 each—the equivalent of $8.10 to $9.10. That represents 12.2% of its enlarged share capital and will value the company at up to $28.5 billion.
    Six cornerstone investors, including investment firms BlackRock , Tiger Global and Hillhouse, will buy up to $1.35 billion of stock wherever the deal is priced. The IPO could increase to $4 billion if underwriting banks exercise an option to buy 15% more shares.
    JD Health plans to fix the offer price on Dec. 1 and list on Dec. 8. The deal is being led by units of Bank of America Corp ., Haitong International Securities Group Ltd . and UBS Group AG . JD Health is on track to set a record for the largest healthcare sector IPO in Asia.
    It could overtake Japanese pharma company Otsuka Holdings Co (OTC: OTSKY), which has held the record for almost a decade with its $2.3 billion IPO in 2010.
  • W
    Woky
    Listing subsidiaries like JD Health and Logistics unlock and increase JD valuation and increase JD book value. It raised cash for them to expand and compete without draining JD's cash flow. They are also majority-owned and thus JD can still add their revenue as part of JD.

    All said and done, it will not directly make the share price higher but it does make JD looks cheaper and less stretched vs their peers.
  • W
    Woky
    JD Health narrowed valuation to U$26B-$29B valuation (was $20B). Likely IPO price $62-$70. Pricing at around 7 times forward earnings, it is a 17% discount to current Alibaba Health current valuation.

    Cornerstone investors onboard include Hill House Capital (who else) and GIC (Singapore gov)
  • W
    Woky
    According to local Chinese media, HKSE will include secondary listed companies like BABA, NTES and JD into the Stock Connect program. Last time the did it was last year December for Meituan and Xiaomi (up 400 and 300% after the program induction)

    NTES/BABA/JD up in HK today as a result.

    In case you wondering, Stock Connect allow Mainland Chinese funds/consumers to buy JD.
  • J
    Jason
    Unfortunately, looks like tech companies including JD have been excluded from the Stock Connect program, for now:
    https://www.theedgemarkets.com/article/hong-kong-expand-chinas-trading-link-star-board-biotech-stocks
  • W
    Woky
    Now there are reports that JD logistics is also planning IPO, probably in the US, for a valuation of no lesser than U$40B. Target early next year.
  • C
    CT
    China's second-largest e-commerce operator is spinning off its online pharmacy and health clinic JD Health in a $3.4 billion IPO in Hong Kong
  • j
    jamil r
    Thank you for today’s deep.. Add 500 more in my portfolio. Happy thanksgiving everyone!
  • P
    Paul
    Happy Thanksgiving everyone. Let’s all be grateful that we bought this stock.
  • H
    Herman
    lookin forward to JD Health IPO then JD Logistics next
  • S
    Samarth
    This is more transformative and much larger than Tesla (which as 4-5x the market cap). I think we should see 100 by EOY and 140-150 by next year. Sales are increasing 30%+
  • 💃
    It closed at $90 in Frankfurt and HK today. Will only go up here tomorrow. Whatever they did, there was no reason they did it to hurt JD investors at least long term. Tell me I am wrong with reasons.
  • K
    Kenny
    JD Health is going to open retail books on November 25 to raise about $4billion. It is expected to start trading on December 7 or 8. JD Health is already profitable, while its listed competitors Ping An Healthcare Technology and Ali Health are still in the red.
  • h
    humza
    We just need to break out of this current trading range and hopefully the IPO of JD health helps us
  • C
    CT
    hold tight to break up above $90. a strong shopping season and coming JD health IPO.
  • j
    jason
    Typical JD sell off right after touching $90 and then a sell off. Maybe there will be some forward momentum after IPO. Once again after JD’s solid ER the stock dropped too.

    I’m long on the stock. Just curious with their recent volatility
  • C
    CT
    JD health is going to IPO, will add more value to ID. the shipping at the end of year will add more revenues. hold and long
  • m
    mr.shortbed
    I think longs are in a good position!
    Quarterly Earnings Growth (yoy) 1,134.80%
  • e
    ethan
    Just bought another 500 shares. Breaking 100 by end of next week. JD health is the push we needed.